- Service Name
Y-Biologics
- Industry
Biotechnology, Pharmaceutical, Biopharmaceutical, Antibody Drug Development
- Main Value Proposition
Y-Biologics offers cutting-edge antibody drug development solutions that enhance cancer treatment efficacy through innovative technologies.
- Description
Y-Biologics specializes in the research and development of antibody drugs, focusing on innovative therapeutic solutions. The company aims to become a global leader in antibody drug development through superior antibody discovery and platform technology establishment.
- Key Features
PD-1 antibody immuno-oncology drug (YBL-006); Dual antibody platform technology (ALiCE); Innovative pH-dependent antibody technology; Comprehensive human antibody library (Ymax®-ABL)
- Use Cases
The service is most valuable in developing novel cancer therapies, enhancing existing treatments, and collaborating with global pharmaceutical partners for innovative drug solutions.
- Competitive advantages
Strong focus on innovative antibody discovery technologies; Successful partnerships and collaborations in the biotechnology sector; Proven track record of patent registrations and technology transfers
- Strengths
Y-Biologics has a robust pipeline of antibody drugs, a strong intellectual property portfolio, and a commitment to continuous research and development in the field of immuno-oncology.
- Positioning
Y-Biologics positions itself as a leader in the antibody drug development market, focusing on innovative solutions for cancer treatment.
- Audience
The target users include healthcare professionals, pharmaceutical companies, investors in biotechnology, and researchers in the field of immuno-oncology.
- CTA
Learn More
- Tags
Antibody Therapy
Immuno-Oncology
Biotechnology
Drug Development
- Tagline
Exploring Antibodies, Creating Novel Therapeutics
- Tone of Voice
Innovative, Professional, Trustworthy
- Differentiation
The company differentiates itself through its proprietary ALiCE platform and the Ymax®-ABL human antibody library, which provide unique approaches to antibody discovery and development.
- Brand Positioning
The brand identity emphasizes innovation, expertise in antibody research, and a commitment to improving patient outcomes through advanced therapeutic solutions.
- Founded
2007-01-01